These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10845947)

  • 1. Diabetes care needs evidence based interventions to reduce risk of vascular disease.
    Byrne CD; Wild SH
    BMJ; 2000 Jun; 320(7249):1554-5. PubMed ID: 10845947
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Burgess DC; Hunt D; Li L; Zannino D; Williamson E; Davis TM; Laakso M; Kesäniemi YA; Zhang J; Sy RW; Lehto S; Mann S; Keech AC
    Eur Heart J; 2010 Jan; 31(1):92-9. PubMed ID: 19797259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
    Armitage J; Collins R
    Heart; 2000 Oct; 84(4):357-60. PubMed ID: 10995396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myocardial infarction in patients with diabetes mellitus type 2].
    Ochotny R; Piszczek I; Błaszyk K; Poprawski K
    Kardiol Pol; 1988; 31(9):563-8. PubMed ID: 3244232
    [No Abstract]   [Full Text] [Related]  

  • 5. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Critical evaluation of a "therapeutic study"].
    Praxis (Bern 1994); 1997 Oct; 86(41):1603-7. PubMed ID: 9417581
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.
    Venskutonyte L; Malmberg K; Norhammar A; Wedel H; Rydén L
    J Intern Med; 2010 Jul; 268(1):75-82. PubMed ID: 20210844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic abnormalities in diabetes mellitus: association between T-wave changes and nephropathy.
    Faierman D; Bloomgarden ZT; Nechemias C; Brown WV
    Mt Sinai J Med; 1986 Apr; 53(4):254-9. PubMed ID: 3487720
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
    MMW Fortschr Med; 2003 Jan; 145(3-4):54-5. PubMed ID: 12619235
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T
    Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate).
    Richter B; Berger M
    Diabetologia; 2000 Apr; 43(4):528-32. PubMed ID: 10819251
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?
    Athyros VG; Mitsiou EK; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Vasc Pharmacol; 2010 Jan; 8(1):1-4. PubMed ID: 20394107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of Type 2 diabetes mellitus- a randomized prospective 8 years follow-up study.
    Rachmani R; Slavachevski I; Berla M; Frommer-Shapira R; Ravid M
    Diabet Med; 2005 Apr; 22(4):410-4. PubMed ID: 15787665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for a reduction of myocardial infarctions by acarbose.
    van de Laar FA; Lucassen PL
    Eur Heart J; 2004 Jul; 25(13):1179; author reply 1179-80. PubMed ID: 15231377
    [No Abstract]   [Full Text] [Related]  

  • 18. [High blood glucose in diabetics a risk factor in acute myocardial infarction. Intensive insulin therapy--an interesting but not functioning idea].
    Dellborg M; Svensson AM
    Lakartidningen; 2006 Sep 13-19; 103(37):2624-5. PubMed ID: 17022181
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.
    Costa J; Borges M; David C; Vaz Carneiro A
    BMJ; 2006 May; 332(7550):1115-24. PubMed ID: 16585050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia.
    Hayes AJ; Leal J; Kelman CW; Clarke PM
    Diabet Med; 2011 Apr; 28(4):428-35. PubMed ID: 21392064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.